The global hyperosmotic laxatives market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of constipation and other gastrointestinal disorders, which are major causes for the use of laxatives. The increasing awareness about the benefits of using laxatives is also driving this market.
The global hyperosmotic laxative market is segmented on the basis of type into lactulose type, polymer type, saline type; on the basis of application into oral used and enemas used; and on the basis of region into North America, Latin America, Europe, Asia Pacific and Middle East & Africa.
- The increasing prevalence of obesity and metabolic syndrome is driving the demand for hyperosmotic laxatives.
- The growing elderly population is also a major factor driving the growth of this market, as they are more likely to suffer from constipation and other gastrointestinal disorders that require treatment with hyperosmotic laxatives.
- Increasing awareness about the benefits of using these products will also drive the growth of this market in coming years.
- The rising incidence of chronic diseases such as diabetes, which can lead to constipation, will also fuel the demand for these products in coming years.
- Increasing awareness about health benefits associated with regular bowel movements will be another key driver for this market.
Industry Growth Insights published a new data on “Hyperosmotic Laxatives Market”. The research report is titled “Hyperosmotic Laxatives Market research by Types (Lactulose Type, Polymer Type, Saline Type), By Applications (Oral Used, Enemas Used), By Players/Companies Abbott, Morinaga, Fresenius Kabi, Illovo, Biofac, Bayer AG, Boehringer Ingelheim, GSK, Purdue Pharma, Sucampo Pharmaceuticals, Beutlich Pharmaceuticals LLC, Safeway, C.B. Fleet Company, Salix Pharmaceuticals”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hyperosmotic Laxatives Market Research Report
By Type
Lactulose Type, Polymer Type, Saline Type
By Application
Oral Used, Enemas Used
By Companies
Abbott, Morinaga, Fresenius Kabi, Illovo, Biofac, Bayer AG, Boehringer Ingelheim, GSK, Purdue Pharma, Sucampo Pharmaceuticals, Beutlich Pharmaceuticals LLC, Safeway, C.B. Fleet Company, Salix Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Hyperosmotic Laxatives Market Report Segments:
The global Hyperosmotic Laxatives market is segmented on the basis of:
Types
Lactulose Type, Polymer Type, Saline Type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oral Used, Enemas Used
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Morinaga
- Fresenius Kabi
- Illovo
- Biofac
- Bayer AG
- Boehringer Ingelheim
- GSK
- Purdue Pharma
- Sucampo Pharmaceuticals
- Beutlich Pharmaceuticals LLC
- Safeway
- C.B. Fleet Company
- Salix Pharmaceuticals
Highlights of The Hyperosmotic Laxatives Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lactulose Type
- Polymer Type
- Saline Type
- By Application:
- Oral Used
- Enemas Used
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hyperosmotic Laxatives Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hyperosmotic laxatives are medications that increase the amount of water in the intestines. This can cause diarrhea and dehydration.
Some of the major companies in the hyperosmotic laxatives market are Abbott, Morinaga, Fresenius Kabi, Illovo, Biofac, Bayer AG, Boehringer Ingelheim, GSK, Purdue Pharma, Sucampo Pharmaceuticals, Beutlich Pharmaceuticals LLC, Safeway, C.B. Fleet Company, Salix Pharmaceuticals.
The hyperosmotic laxatives market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hyperosmotic Laxatives Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hyperosmotic Laxatives Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hyperosmotic Laxatives Market - Supply Chain
4.5. Global Hyperosmotic Laxatives Market Forecast
4.5.1. Hyperosmotic Laxatives Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hyperosmotic Laxatives Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hyperosmotic Laxatives Market Absolute $ Opportunity
5. Global Hyperosmotic Laxatives Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hyperosmotic Laxatives Market Size and Volume Forecast by Type
5.3.1. Lactulose Type
5.3.2. Polymer Type
5.3.3. Saline Type
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hyperosmotic Laxatives Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hyperosmotic Laxatives Market Size and Volume Forecast by Application
6.3.1. Oral Used
6.3.2. Enemas Used
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hyperosmotic Laxatives Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hyperosmotic Laxatives Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hyperosmotic Laxatives Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hyperosmotic Laxatives Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hyperosmotic Laxatives Demand Share Forecast, 2019-2026
9. North America Hyperosmotic Laxatives Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hyperosmotic Laxatives Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hyperosmotic Laxatives Market Size and Volume Forecast by Application
9.4.1. Oral Used
9.4.2. Enemas Used
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hyperosmotic Laxatives Market Size and Volume Forecast by Type
9.7.1. Lactulose Type
9.7.2. Polymer Type
9.7.3. Saline Type
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hyperosmotic Laxatives Demand Share Forecast, 2019-2026
10. Latin America Hyperosmotic Laxatives Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hyperosmotic Laxatives Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hyperosmotic Laxatives Market Size and Volume Forecast by Application
10.4.1. Oral Used
10.4.2. Enemas Used
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hyperosmotic Laxatives Market Size and Volume Forecast by Type
10.7.1. Lactulose Type
10.7.2. Polymer Type
10.7.3. Saline Type
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hyperosmotic Laxatives Demand Share Forecast, 2019-2026
11. Europe Hyperosmotic Laxatives Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hyperosmotic Laxatives Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hyperosmotic Laxatives Market Size and Volume Forecast by Application
11.4.1. Oral Used
11.4.2. Enemas Used
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hyperosmotic Laxatives Market Size and Volume Forecast by Type
11.7.1. Lactulose Type
11.7.2. Polymer Type
11.7.3. Saline Type
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Mrket Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hyperosmotic Laxatives Demand Share, 2019-2026
12. Asia Pacific Hyperosmotic Laxatives Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hyperosmotic Laxatives Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hyperosmotic Laxatives Market Size and Volume Forecast by Application
12.4.1. Oral Used
12.4.2. Enemas Used
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hyperosmotic Laxatives Market Size and Volume Forecast by Type
12.7.1. Lactulose Type
12.7.2. Polymer Type
12.7.3. Saline Type
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hyperosmotic Laxatives Demand Share, 2019-2026
13. Middle East & Africa Hyperosmotic Laxatives Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hyperosmotic Laxatives Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hyperosmotic Laxatives Market Size and Volume Forecast by Application
13.4.1. Oral Used
13.4.2. Enemas Used
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hyperosmotic Laxatives Market Size and Volume Forecast by Type
13.7.1. Lactulose Type
13.7.2. Polymer Type
13.7.3. Saline Type
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hyperosmotic Laxatives Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hyperosmotic Laxatives Market: Market Share Analysis
14.2. Hyperosmotic Laxatives Distributors and Customers
14.3. Hyperosmotic Laxatives Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Morinaga
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Fresenius Kabi
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Illovo
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Biofac
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bayer AG
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Boehringer Ingelheim
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. GSK
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Purdue Pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sucampo Pharmaceuticals
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Beutlich Pharmaceuticals LLC
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Safeway
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. C.B. Fleet Company
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Salix Pharmaceuticals
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
